Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Dose Response Study of Patients With Erythematous Rosacea
This study has been completed.
Study NCT01186068 Information provided by Vicept Therapeutics, Inc.
First Received on August 17, 2010. Last Updated on November 22, 2010
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Erythematous (Type One) Rosacea
Additional conditions recognized in this trial
Rosacea
More general conditions related to this trial
Skin Diseases
Interventions listed in this trial
V-101
vehicle
Sponsors listed in this trial
Vicept Therapeutics, Inc.
Accenture
Back to top of Main Content